https://www.selleckchem.com/products/gdc6036.html
Human amniotic mesenchymal stem cells (hAMSCs) are splendid cell sources for clinical application in the administration of numerous refractory and relapse diseases. Despite the preferable prospect of serum-free (SF) condition for cell product standardization and pathogenic contamination remission, yet the systematic and detailed impact upon hAMSCs at both cellular and transcriptomic levels is largely obscure. For the purpose, we preconditioned hAMSCs under serum-containing (SC) and SF medium for 48h and compared the biological signature
Curtir
Comentario
Compartilhar
